Gynecologic Cancer,Other Cancers Maintenance Selinexor vs Placebo in Endometrial Cancer: SIENDO Study May 08, 2023
Gynecologic Cancer,Other Cancers Rucaparib Maintenance Benefit in High-Grade Ovarian Carcinoma: ARIEL3 Exceptional Responders May 08, 2023
Gynecologic Cancer,Other Cancers Lenvatinib + Pembrolizumab in Advanced Endometrial Cancer: Updated KEYNOTE-775 Results May 08, 2023
Other Cancers Selumetinib vs. Placebo: Assessing Complete Remission in Differentiated Thyroid Cancer May 08, 2023
Other Cancers Phase III Trial Comparing 177Lu-Edotreotide with Standard Care for GEP-NETs (Grades 2 and 3) May 08, 2023
Other Cancers Cabozantinib vs Placebo in RAIR DTC Patients: Outcomes by Prior Lenvatinib Duration May 08, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab, Quavonlimab, and Lenvatinib in Treatment of ccRCC May 08, 2023
